Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amra Macic-Džanković"'
Publikováno v:
Scripta Medica. 48:108-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb51807e1a6afa686dbe848c1d4ee373
https://doi.org/10.18575/msrs.sm.s.17.15
https://doi.org/10.18575/msrs.sm.s.17.15
Publikováno v:
Scripta Medica. 48:108-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e302f6c87af0367678382655c4cc96af
https://doi.org/10.18575/msrs.sm.e.17.15
https://doi.org/10.18575/msrs.sm.e.17.15
Publikováno v:
Frontiers in Clinical Diabetes and Healthcare, Vol 4 (2023)
Glucagon like peptide-1 (GLP-1) receptor agonists are well established drugs for the treatment of type 2 diabetes (T2D). In addition to glycemic control, GLP-1 receptor agonists have beneficial other effects. They act by binding to GLP-1 receptors, w
Externí odkaz:
https://doaj.org/article/129c7890af8841bcb33da7276f5e61c2
Autor:
Adlija Čaušević, Sabina Semiz, Amra Macić-Džanković, Bakira Cico, Tanja Dujić, Maja Malenica, Tamer Bego
Publikováno v:
Biomolecules & Biomedicine, Vol 10, Iss 1 (2010)
Recent studies have introduced serum uric acid (UA) as a potential risk factor for developing diabetes, hypertension, stroke, and cardiovascular diseases. The value of elevated levels of UA in serum as a risk factor for diabetes development is still
Externí odkaz:
https://doaj.org/article/3c0c84df0c2c4b30ac0f674d4e6b2156
Publikováno v:
Biomolecules & Biomedicine, Vol 9, Iss 4 (2009)
The aim of this study was to examine the effects of hypoglycaemic drug-agonists of PPAR-gama recep- tors-rosiglitazone (Avandia,4 mg - Glaxo Smith Kline) on values of wide-spread risk-markers: fibrinogen, C-reactive protein and uric acid and glicolys
Externí odkaz:
https://doaj.org/article/3f48af87b3a24f0e81dd73708bd7493d
Publikováno v:
Biomolecules & Biomedicine, Vol 8, Iss 3 (2008)
An unusual case of cardiac sarcoidosis is described. A woman with biopsy proven lung sarcoidosis was presented on admission in hospital as ventricular tachycardia and non Q myocardial infarction. Ultrasound of the heart and coronarography examination
Externí odkaz:
https://doaj.org/article/c9b22ce1877e47f59672f3f63aa1b758
Publikováno v:
Biomolecules & Biomedicine, Vol 7, Iss 4 (2007)
Department of Cardiology, General Hospital "Prim. dr Abdulah Nakas", Kranjcevićeva 12, 71000 Sarajevo, Bosnia and Herzegovina. Twenty seven patients diagnosed as having systolic heart failure with Ejection Fraction (EF) of less than 40% by echocar
Externí odkaz:
https://doaj.org/article/568016e20deb4d2b91aea6fd66f39019
Autor:
Amra Macić-Džanković, Belma Pojskić
Publikováno v:
Biomolecules & Biomedicine, Vol 7, Iss 1 (2007)
We compared two groups of patients after acute myocardial infarction. First group was treated with fibrinolytics and they were hospitalized within six hours from the beginning of the first chest-symptoms, and second group that did not come within opt
Externí odkaz:
https://doaj.org/article/f13e3bfa1d884bd78bc3475833fce597
Autor:
Zumreta Kušljugić, Katarina Divković, Fahir Baraković, Elnur Smajić, Amila Arslanagić, Mustafa Hadžiomerović, Emir Fazlibegović, Zlatico Midžić, Enes Abdović, Milenko Krneta, Radenko Čelik, Hajro Bašić, Bajro Avdić, Adnan Delić, Amra Macić-Džanković, Nedžad Kečo, Hajra Boškailo
Publikováno v:
Biomolecules & Biomedicine, Vol 5, Iss 1 (2005)
Hypertension is a major risk factor for cardiovascular diseases; drugs that reduce blood pressure and simultaneously improve or reverse endothelian dysfunction, as nebivolol, may be advantageous in terms of cardiovascular protection. The objective of
Externí odkaz:
https://doaj.org/article/ebfef610994243cc90d28e7a5b8d47c5